Pectogen is thrilled to enter the third phase of the CAI Breast Cancer Start-up Competition. We are dedicated to improving the lives of cancer patients by delivering innovative hydrogel-based delivery approaches to market. Our flagship product combines surgery and oncology disciplines into a best-in-class reconstructive option with potential therapeutic benefit. Over the past couple of weeks, we have outlined a rough operating agreement, engaged with leading researchers to discuss short- and long-term R&D plans, spoken with other groups to discuss potential collaborations, and outlined the licensing process with the office of technology transfer. Our team, with its diverse set of backgrounds and skillsets, has put us on a path to an exclusive license for this patent which will enable us to drive this important technology towards market. Frank Glaser Brian Hasselfeld Parastoo Khoshakhlagh